Simplex Trading’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,188
Closed -$2.22K – 9317
2026
Q2
$1.31K Buy
2,188
+2,133
+3,878% +$2.05K ﹤0.01% 8776
2026
Q1
$73 Sell
55
-4,548
-99% -$5.76K ﹤0.01% 8889
2025
Q4
$5.11K Sell
4,603
-4,848
-51% -$8.69K ﹤0.01% 7420
2025
Q3
$19K Sell
9,451
-7,953
-46% -$22.3K ﹤0.01% 7356
2025
Q2
$34K Buy
17,404
+6,498
+60% +$11.8K ﹤0.01% 6283
2025
Q1
$18K Buy
10,906
+9,363
+607% +$17.7K ﹤0.01% 6642
2024
Q4
$3K Sell
1,543
-1,925
-56% -$4.59K ﹤0.01% 7844
2024
Q3
$10K Sell
3,468
-1,964
-36% -$5.79K ﹤0.01% 7173
2024
Q2
$17K Buy
5,432
+3,675
+209% +$12.8K ﹤0.01% 7023
2024
Q1
$9K Buy
+1,757
New +$7.22K ﹤0.01% 7657
2023
Q2
– Sell
-98
Closed -$628 – 9045
2023
Q1
$0 Sell
98
-222
-69% -$1.79K ﹤0.01% 9099
2022
Q4
$4K Buy
+320
New +$5.9K ﹤0.01% 8176
2022
Q3
– Sell
-3,806
Closed -$116K – 9967
2022
Q2
$129K Buy
3,806
+3,801
+76,020% +$309K ﹤0.01% 5208
2022
Q1
$0 Sell
5
-548
-99% -$32.8K ﹤0.01% 10464
2021
Q4
$28K Buy
+553
New +$35.4K ﹤0.01% 7978
2021
Q2
– Sell
-6,095
Closed -$618K – 10079
2021
Q1
$614K Buy
+6,095
New +$625K ﹤0.01% 3067

Other funds holding CELU

Simplex Trading's CELU Position: Q3 2026 in Review

Simplex Trading sold out of Celularity (CELU) in Q3 2026, closing a stake of 2,188 shares — an estimated $2.22K sold.

Simplex Trading first reported a position in CELU in Q1 2021 and held it in 16 quarters. The position peaked at $614K in Q1 2021. 27 funds tracked by Wall St. Rank hold CELU as of Q3 2026.

  • Simplex Trading reported no remaining Celularity position as of Q3 2026 after selling out during the quarter.
  • Simplex Trading sold 2,188 Celularity shares in Q3 2026, an estimated $2.22K.
  • Simplex Trading first reported a position in Celularity in Q1 2021 and held it in 16 quarters.
  • Simplex Trading's Celularity position peaked at $614K in Q1 2021.
  • 27 funds tracked by Wall St. Rank held Celularity as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.